ZO Skin Health to launch new comprehensive medical skincare line

ZO® Skin Health By Zein Obagi, M.D. is pleased to announce the global launch of a new comprehensive medical skincare line, ZO® Medical, at the American Academy of Dermatology Annual Meeting.

To kick off this important launch, ZO® Skin Health experts will be on hand in Booth #4207 to give demonstrations of the 11 products in the range which will be sold exclusively in leading physician practices throughout the US and Canada. Created by Zein Obagi, M.D., the science behind ZO® Medical represents Dr. Obagi's proven way of thinking about and caring for skin by repairing it at the cellular level.  The products were developed to work synergistically from the inside out, activating and stimulating skin's cells to nourish, repair and maintain healthy skin.

The new line centers around Dr. Obagi's ZO® philosophy of the Skin Health Circle™ which uses ZO® Medical solutions to address a wide range of applications—therapeutic, maintenance, daily skin care, and protection. ZO® Medical utilizes the most potent ingredients in high concentrations, pure retinol, advanced peptides, and powerful antioxidants.

"ZO® Medical will raise the bar on skin health, providing topical solutions with advanced levels of tested, potent, proven ingredients," states Dr. Obagi.  "This line is the culmination of decades of learnings and outcomes with a unique proven approach to skincare. I am very excited to unveil ZO® Medical at the AAD Annual Meeting to my colleagues and partners in Dermatology."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover the potential of JAK inhibitors to treat life-threatening skin disease